Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Capital/Financing Update 2025

Jan 23, 2025

62616_rns_2025-01-23_417503a1-9e1e-4ef8-8454-62d6cddbe556.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [145 x 47] intentionally omitted <==

January 23, 2025

BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001

Scrip code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051

Scrip code: STAR

Dear Madam/ Sirs,

  • Sub: OneSource Specialty Pharma Limited (OneSource) - India’s first Specialty Pharma CDMO receives Listing and Trading approval for its Equity Shares from BSE and NSE.

OneSource to start trading in NSE and BSE from January 24, 2025

We wish to inform you that OneSource has received Final Listing and Trading approval for its Equity Shares from the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on Wednesday, January 22, 2025 .

Scrip Code of OneSource is as under:

  • NSE: ONESOURCE

  • BSE: 544292

OneSource shall start trading on NSE and BSE from Friday, January 24, 2025 onwards.

You are kindly requested to take the same on record.

Thanks & Regards, For Strides Pharma Science Limited,

MANJULA R

Digitally signed by MANJULA R Date: 2025.01.23 10:57:28 +05'30'

Manjula Ramamurthy Company Secretary ICSI Membership No. A30515

==> picture [479 x 50] intentionally omitted <==